Key Escrow in Medical Device Cybersecurity: Risks & Controls

Encryption is foundational to modern medical device cybersecurity. Devices rely on cryptographic keys for firmware signing, device identity, secure communications, data-at-rest protection, and cloud authentication.

But an uncomfortable question often follows:

What happens if a critical key is lost, corrupted, or compromised?

This is where key escrow enters the conversation. In regulated medical device ecosystems, escrow is not simply a security feature - it is a governance decision with real operational and risk tradeoffs.

Why this matters

The FDA's Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions (Feb 3, 2026 final guidance) made cybersecurity documentation a gating criterion for clearance under Section 524B of the FD&C Act. Reviewers now apply this guidance to key escrow in medical device cybersecurity the same way they apply software lifecycle expectations from IEC 62304 and security risk-management expectations from AAMI TIR57 and ANSI/AAMI SW96:2023.

Gaps in this area are the single most common driver of first-cycle cybersecurity Additional Information (AI) requests. The FDA's FY2024 CDRH performance reports show cybersecurity is among the top deficiency categories cited in 510(k) and PMA AI letters, behind only software documentation and clinical evidence. Treating it as a checklist exercise rather than a design-controlled engineering artifact is what creates the gap.

What Is Key Escrow?

Key escrow is the practice of securely storing a copy of a cryptographic key with a trusted third party or controlled internal mechanism so it can be recovered under defined circumstances.

In practical terms, it means that encryption keys are not exclusively controlled by a single person or system without recovery options.

Escrow may be used for:

• Disaster recovery
• Business continuity
• Legal compliance scenarios
• Organizational key custodian turnover

However, escrow also increases exposure if not governed properly.

Why Key Escrow Is Complex in Medical Devices

Medical device ecosystems often rely on multiple classes of cryptographic keys:

• Firmware signing keys
• Secure boot keys
• Device identity certificates
• TLS server certificates
• Cloud API tokens
• Data-at-rest encryption keys

Each key type has different risk implications.

For example:

• If a firmware signing key is lost, devices may no longer accept legitimate updates.
• If a signing key is compromised, attackers may distribute malicious firmware.
• If a cloud encryption key is unavailable, patient data may become inaccessible.

Escrow decisions must therefore balance availability and security.

When Key Escrow May Be Appropriate

1. Firmware Signing Continuity

If only one individual controls a firmware signing key and that key is lost, update capability can halt. Escrow mechanisms - especially when protected by hardware security modules (HSMs) and dual control - may support controlled recovery.

2. Data-at-Rest Recovery

Cloud-stored PHI encrypted with a single unrecoverable key presents operational risk. Escrow, combined with strict access governance, may support disaster recovery objectives.

3. Enterprise Governance Requirements

Larger organizations may require escrow under internal governance or regulatory compliance frameworks to ensure continuity of critical systems.

When Key Escrow May Not Be Appropriate

1. Device Identity Keys

Escrowing device private keys can introduce systemic compromise risk. In many architectures, device identity keys should remain unique and non-exportable.

2. High-Sensitivity Root Keys

Root certificate authority (CA) keys or platform root-of-trust keys are high-value targets. If escrow expands exposure or introduces additional access paths, the risk may outweigh the recovery benefit.

3. Environments Without Strong Governance Controls

If the organization cannot enforce dual control, logging, access reviews, and strict separation of duties, escrow may increase insider or operational risk.

Risks Introduced by Key Escrow

• Single point of compromise if escrow storage is breached
• Insider abuse without separation of duties
• Audit failures if access events are not logged
• Increased attack surface through additional key access paths

See also: NeuroTech Cybersecurity Risks: Neurostimulators, EEG, & BCI, The Overlooked Threat in MedTech Innovation, and QNX Vulnerabilities in Medical Devices.

Escrow is not neutral. It must be implemented intentionally and defensibly.

Secure Implementation Controls

If escrow is used in a medical device ecosystem, strong safeguards are essential:

• Hardware Security Modules (HSMs) for key storage
• Dual control / split knowledge for key recovery
• Role-based access control with least privilege
• Comprehensive audit logging
• Periodic access review and testing
• Documented key rotation policies

Many manufacturers align cryptographic governance with structured secure development practices such as NIST SP 800-218 (Secure Software Development Framework).

FDA Cybersecurity Expectations and Cryptographic Governance

FDA’s cybersecurity guidance emphasizes lifecycle integration of security controls and traceable documentation of risk management decisions.

Manufacturers should be prepared to demonstrate:

• Threat modeling of cryptographic key compromise scenarios
• Risk-based justification for escrow decisions
• Verification testing of key protection mechanisms
• Documented recovery procedures
• Postmarket response plans for key compromise

See FDA’s cybersecurity guidance here: Cybersecurity in Medical Devices (Premarket + QMS Considerations).

Escrow decisions should align with ISO 14971 risk management documentation and be traceable to safety and effectiveness considerations.

Postmarket Implications

Key compromise after product deployment requires rapid containment and recovery. Manufacturers should have predefined procedures for:

• Revocation of compromised certificates
• Secure firmware re-signing
• Communication to customers and regulators
• Patch distribution planning

If escrow exists, its recovery process should be tested periodically under controlled conditions.

Key Takeaways

• Key escrow is a governance decision, not a default best practice.
• It can support continuity but increases exposure if poorly controlled.
• Different key types require different escrow considerations.
• Strong HSM protection and dual control are essential safeguards.
• FDA expectations require lifecycle documentation and verification evidence.

Table of Contents

• What Is Key Escrow?
• Why Key Escrow Is Complex in Medical Devices
• When Key Escrow May Be Appropriate
• When Key Escrow May Not Be Appropriate
• Risks Introduced by Key Escrow
• Secure Implementation Controls
• FDA Cybersecurity Expectations and Cryptographic Governance
• Postmarket Implications
• Key Takeaways
• Need Help Strengthening Cryptographic Governance?
• Related FDA & cybersecurity guides

How Blue Goat approaches this

Blue Goat Cyber's medical device practice is led by engineers with CISSP, OSCP, and prior military red-team backgrounds. We treat cybersecurity documentation as design-controlled engineering output, not a submission template, every artifact (threat model, SBOM, security risk assessment, penetration test, labeling) traces back to a controlled requirement and a verified result.

Our engagements deliver the full Feb 3, 2026 guidance documentation set scoped to the device's risk profile, integrated with the existing IEC 62304 software lifecycle and ISO 14971 risk file. See our medical device cybersecurity services for the full scope. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost.

FAQ

Is key escrow required for medical device cybersecurity?

No. It is a risk-based governance decision. Some environments require it for continuity; others avoid it for high-sensitivity keys.

Does escrow weaken encryption?

Escrow does not weaken encryption mathematically, but it increases exposure pathways if not properly governed.

Should firmware signing keys be escrowed?

In some organizations, controlled escrow supports update continuity. However, strict HSM protection and dual control are essential.

What is the biggest risk of key escrow?

Concentration of key access without sufficient governance controls, creating a high-value compromise target.

How does escrow align with FDA cybersecurity guidance?

FDA expects risk-based decision-making, lifecycle integration, and documented controls. Escrow decisions should be justified, tested, and monitored.

Need Help Strengthening Cryptographic Governance?

If your device ecosystem relies on firmware signing, device identity, or cloud encryption keys, validating your key management architecture can reduce regulatory and operational risk.

Book a Discovery Session

Related FDA & cybersecurity guides

• FDA Section 524B cybersecurity requirements explained
• SBOM vulnerability management for medical devices
• VEX document guide for FDA submissions
• FDA deficiency-letter response service
• STRIDE threat modeling for medical devices

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.